BACKGROUND: Dexmedetomidine is an α 2-receptor agonist used for sedation in the intensive care unit (ICU). Although dexmedetomidine is labeled for sedation in critically ill patients at doses up to ...
Please provide your email address to receive an email when new articles are posted on . DALLAS — Critically ill patients undergoing mechanical ventilation in the ICU who received early sedation with ...
In a multicenter, double-blind trial, we randomly assigned mechanically ventilated adults with sepsis to receive dexmedetomidine (0.2 to 1.5 μg per kilogram of body weight per hour) or propofol (5 to ...
We report the use of dexmedetomidine infusion in critically ill infants and children at doses of 0.2–0.7 μg/kg/hr for a median duration of 141 hours. The major findings from our study include 1) ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...
Please provide your email address to receive an email when new articles are posted on . Mortality, sedation quality and delirium in those receiving dexmedetomidine or clonidine did not differ from ...
Laparoscopic minimally invasive surgery has been widely used in the diagnosis and treatment of gynaecological diseases. To investigate the effect of dexmedetomidine on perioperative haemodynamics and ...
Introduction: Perioperative sleep disorders constitute a recognized risk factor for multiple postoperative complications. Although dexmedetomidine (DEX) has been clinically employed to enhance ...
WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results